Opportunities Exist for CMS and Its Medicare Contractors To Strengthen Program Safeguards To Prevent and Detect Improper Payments for Drug Testing Services
University of Michigan Health System: Audit of Medicare Payments for Polysomnography Services
New Mexico Did Not Bill Manufacturers for Some Rebates for Physician-Administered Drugs Dispensed to Enrollees of Medicaid Managed-Care Organizations
Medicare Home Health Agency Provider Compliance Audit: Caretenders of Jacksonville, LLC
FY 2022 Congressional Budget Justification
Spring 2021 Semiannual Report to Congress
Medicare Made Millions of Dollars in Overpayments for End-Stage Renal Disease Monthly Capitation Payments
Medicare Advantage Compliance Audit of Specific Diagnosis Codes That Anthem Community Insurance Company, Inc. (Contract H3655) Submitted to CMS
Medicare Hospice Provider Compliance Audit: Alive Hospice, Inc.
Medicare Hospice Provider Compliance Audit: Ambercare Hospice, Inc.
Advisory Opinion 21-03
U.S. Department of Health and Human Services Met Many Requirements, but It Did Not Fully Comply With the Payment Integrity Information Act of 2019 and Applicable Improper Payment Guidance for Fiscal Year 2020
CMS Needs to Strengthen Regulatory Requirements for Medicare Part B Outpatient Cardiac and Pulmonary Rehabilitation Services to Ensure Providers Fully Meet Coverage Requirements
Minnesota Made Capitation Payments to Managed Care Organizations for Medicaid Beneficiaries With Concurrent Eligibility in Another State
New York Made Unallowable Payments Totaling More Than $9 Million to the Same Managed Care Organization for Beneficiaries Assigned More Than One Medicaid Identification Number
Medicare Could Have Saved up to $20 Million Over 5 Years if CMS Oversight Had Been Adequate To Prevent Payments for Medically Unnecessary Cholesterol Blood Tests